Neurogene Inc. (NASDAQ:NGNE) Receives $60.83 Consensus PT from Analysts
Shares of Neurogene Inc. (NASDAQ:NGNE – Get Free Report) have been assigned a consensus rating of “Buy” from the eight research firms that are currently covering the firm, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month […]
More Stories
Enterprise Products Partners Target of Unusually Large Options Trading (NYSE:EPD)
Enterprise Products Partners L.P. (NYSE:EPD – Get Free Report) saw some unusual options trading on Tuesday. Stock traders acquired 34,749...
High Income Securities Fund (NYSE:PCF) Short Interest Update
High Income Securities Fund (NYSE:PCF – Get Free Report) was the recipient of a significant decline in short interest during...
Royalty Pharma Target of Unusually Large Options Trading (NASDAQ:RPRX)
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) saw some unusual options trading on Tuesday. Stock investors purchased 2,751 call...
Ximen Mining (CVE:XIM) Trading Down 20% – Should You Sell?
Ximen Mining Corp. (CVE:XIM – Get Free Report) fell 20% during mid-day trading on Tuesday . The company traded as...
Short Interest in GraniteShares 2x Long COIN Daily ETF (NASDAQ:CONL) Drops By 41.1%
GraniteShares 2x Long COIN Daily ETF (NASDAQ:CONL – Get Free Report) was the target of a significant decline in short...
Head to Head Contrast: Bicycle Therapeutics (NASDAQ:BCYC) and Sycamore Entertainment Group (OTCMKTS:SEGI)
Sycamore Entertainment Group (OTCMKTS:SEGI – Get Free Report) and Bicycle Therapeutics (NASDAQ:BCYC – Get Free Report) are both consumer discretionary...